UBI was one of the buy recommendations in the Herald Sun today.
”UBI develops and manufactures devices for the diagnostic point-of-care market.
With a market cap of only $84m UBI is cheap, even after rising 150% in 2020.”
Add to My Watchlist
What is My Watchlist?